187 related items for PubMed ID: 24560184
1. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.
Sarafoglou K, Addo OY, Turcotte L, Otten N, Wickremasinghe A, Pittock S, Kyllo J, Lteif AN, Himes JH, Miller BS.
J Pediatr; 2014 May; 164(5):1141-1146.e1. PubMed ID: 24560184
[Abstract] [Full Text] [Related]
2. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[Abstract] [Full Text] [Related]
3. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
Turk J Pediatr; 2009 Mar; 51(6):539-44. PubMed ID: 20196386
[Abstract] [Full Text] [Related]
4. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
[Abstract] [Full Text] [Related]
5. Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia.
Ciaccio M, Montiveros C, Rivarola MA, Belgorosky A.
Medicina (B Aires); 2002 Oct 25; 62(6):551-4. PubMed ID: 12532689
[Abstract] [Full Text] [Related]
6. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
Ahmed SEAM, Soliman AT, Ramadan MA, Elawwa A, Abugabal AMS, Emam MHA, De Sanctis V.
Acta Biomed; 2019 Sep 06; 90(3):360-369. PubMed ID: 31580328
[Abstract] [Full Text] [Related]
7. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Sep 06; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
8. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2009 Oct 06; 94(10):3882-8. PubMed ID: 19622620
[Abstract] [Full Text] [Related]
9. [A clinical study of congenital adrenal hyperplasia].
Nanbu A, Kumamoto Y, Tachiki H, Itoh N, Mikuma N, Tsunekawa T, Takagi Y, Maruta H.
Hinyokika Kiyo; 1989 Nov 06; 35(11):1831-7. PubMed ID: 2559616
[Abstract] [Full Text] [Related]
10. Impact of availability of oral hydrocortisone on growth of children with CAH.
Khadilkar VV, Khadilkar AV, Maskati GB.
Indian J Pediatr; 2005 Apr 06; 72(4):301-3. PubMed ID: 15876756
[Abstract] [Full Text] [Related]
11. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB.
J Pediatr Endocrinol Metab; 2012 Apr 06; 25(9-10):977-81. PubMed ID: 23426829
[Abstract] [Full Text] [Related]
12. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP, Winter A, Stolecke H.
Klin Padiatr; 1997 Apr 06; 209(2):71-7. PubMed ID: 9113619
[Abstract] [Full Text] [Related]
13. Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.
Punthakee Z, Legault L, Polychronakos C.
J Pediatr; 2003 Sep 06; 143(3):402-5. PubMed ID: 14517528
[Abstract] [Full Text] [Related]
14. Do All Patients with Congenital Adrenal Hyperplasia Need to Be on Hydrocortisone Three Times a Day in Order to Have Normal Growth?
Logan LA, Nebesio TD, Eckert GJ, Eugster EA.
Horm Res Paediatr; 2022 Sep 06; 95(5):461-464. PubMed ID: 35649383
[Abstract] [Full Text] [Related]
15. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Sep 06; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
16. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
J Pediatr; 2002 Aug 06; 141(2):247-52. PubMed ID: 12183722
[Abstract] [Full Text] [Related]
17. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Aycan Z, Ocal G, Berberoglu M, Cetinkaya E, Adiyaman P, Evliyaoglu O.
J Pediatr Endocrinol Metab; 2006 Mar 06; 19(3):245-51. PubMed ID: 16607925
[Abstract] [Full Text] [Related]
18. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB.
J Clin Endocrinol Metab; 2000 Mar 06; 85(3):1114-20. PubMed ID: 10720048
[Abstract] [Full Text] [Related]
19. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 06; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
20. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2007 May 06; 92(5):1635-9. PubMed ID: 17299071
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
